All times are listed in CET (Central European Time)

Browsing Over 135 Presentations

Sort By
Lung cancer screening: The end of the beginning Educational session

Novel screening approaches

Lecture Time
10:30 - 10:45
Speakers
  • J. Van Meerbeeck (Edegem, Belgium)
Session Name
Lung cancer screening: The end of the beginning
Room
Channel 1
Date
Thu, 25.03.2021
Time
10:00 - 11:00
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Options in patients with brain metastases

Lecture Time
11:20 - 11:35
Speakers
  • O. Gautschi (Luzern, Switzerland)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
The eternal debate in stage III Multidisciplinary Tumour Board

What is the best local treatment? Surgery

Lecture Time
11:20 - 11:35
Session Name
The eternal debate in stage III
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Role of chemo-free combinations

Lecture Time
11:35 - 11:50
Speakers
  • S. Ramalingam (Atlanta, GA, United States of America)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
The eternal debate in stage III Multidisciplinary Tumour Board

What is the best local treatment? Radiation therapy

Lecture Time
11:35 - 11:50
Speakers
  • M. Werner-Wasik (Philadelphia, PA, United States of America)
Session Name
The eternal debate in stage III
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Role of chemo-IO combinations

Lecture Time
11:50 - 12:05
Speakers
  • F. Cappuzzo (Ravenna, Italy)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
The eternal debate in stage III Multidisciplinary Tumour Board

Don’t forget the systemic treatment

Lecture Time
11:50 - 12:05
Speakers
  • L. Coate (Limerick, Ireland)
Session Name
The eternal debate in stage III
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Role of single agent immunotherapy

Lecture Time
12:05 - 12:20
Speakers
  • M. Garcia Campelo (A Coruña, Spain)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Young oncologists session 1 Young oncologists

TBC

Lecture Time
11:15 - 11:35
Session Name
Young oncologists session 1
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
The eternal debate in stage III Multidisciplinary Tumour Board

IO in stage III

Lecture Time
12:05 - 12:20
Speakers
  • J. Lee (Los Angeles, United States of America)
Session Name
The eternal debate in stage III
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Q&A and live discussion

Lecture Time
12:20 - 12:35
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Presentation of case: Monotherapy or chemoimmunotherapy in PD-L1>50%?

Lecture Time
11:15 - 11:20
Speakers
  • L. Landi (Ravenna, Italy)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35